Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

Previous studies have demonstrated that sera from patients with prostate cancer (PCa) contain autoantibodies that react with tumor-associated antigens (TAAs). Autoantibodies to cyclin B1 and fourteen other TAAs were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting in 464 se...

Full description

Bibliographic Details
Main Authors: Dai, Liping, Li, Jitian, Ortega, Rosalia, Qian, Wei, Casiano, Carlos A., Zhang, Jian-Ying
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016862/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016862/

Similar Items